In the microscopic world, the flow of time seems magnified. Moments, days, even the entire life span of these miniature organs seem to pass in the blink of an eye, revealing everything.

Exhibition Review | BioGenous at BioCon Expo: The Organic Integration of Organoids and Biopharmaceuticals

Amid the sweet osmanthus fragrance and bountiful autumn harvest, the "2nd Organoid Interdisciplinary Summit Forum and Unveiling Ceremony of Shandong Huize Jikang Biomedical Technology Co., Ltd." co-hosted by the Dezhou Economic and Technological Development Zone Administrative Committee and Fudan University, came to a successful close at the Dezhou Zhongyuan Science and Technology Innovation and Entrepreneurship Park in Dezhou, Shandong Province. The operation and production of Huize Jikang marks the official launch of BioGenous Northern GMP Production Center.

Since its establishment last year, BioGenous has always upheld the corporate vision of "Leading Pharmaceutical Innovation, Sharing Model Value." We have launched a series of products including standardized organoid culture kits, full-process organoid establishment kits, and high-activity organoid culture growth factors. To showcase the unique qualities of our organoid culture product line, we are now initiating the "BioGenous High-Activity Organoid Culture Factor Trial Pack" application activity. We also look forward to receiving your feedback and valuable suggestions on our products.

On January 17, the "Eco-Innovation Journey" gala was held in Xiaoshan Innovation Polis.

On December 16, bioGenous was invited to conduct the academic symposium on "Organoid Technology and Translational Research" at Fujian Cancer Hospital.

From December 12 to 15, the 11th Annual Meeting of CSSCR was successfully held at the GYICC. Domestic experts and scholars in the field of stem cells gathered to discuss stem cell research and translation.

Today, the 11th Annual Meeting of the CSC officially opened at the Guangzhou Yuexiu International Congress Center. The conference features presentations by top scientists of stem cells and breakout sessions covering stem cell and regenerative medicine.

To promote the development of the stem cell and regenerative medicine in China and facilitate deeper collaboration and exchange among researchers, the 11th Annual Meeting of CSSCR held in Guangzhou from December 12 to 15, 2021.

On the morning of November 23, BioGenous Biotech conducted the symposium on organoid technology and translational research at the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. During the event, Professor Bing Zhao, Chief Scientist of BioGenous Biotech and professor at Fudan University, delivered a keynote presentation titled "Human Organoids Modeling Development and Disease." Both parties engaged in in-depth discussions about integrating organoid technology with advanced biotechnological engineering and explored potential strategic cooperation.